Foca Gene 4
4 · Getty Images Holdings, Inc. · Filed Sep 21, 2023
Insider Transaction Report
Form 4
Foca Gene
Chief Marketing Officer
Transactions
- Sale
Class A Common Stock
2023-09-19$7.14/sh−200,000$1,428,000→ 335,956 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-09-19$2.74/sh−200,000$548,000→ 1,079,047 totalExercise: $2.74Exp: 2029-04-10→ Class A Common Stock (200,000 underlying) - Exercise/Conversion
Class A Common Stock
2023-09-19$2.74/sh+200,000$548,000→ 535,956 total
Footnotes (3)
- [F1]Transaction made pursuant to a Rule 10b5-1(c) plan adopted on March 15, 2023.
- [F2]This transaction was executed in multiple trades at prices ranging from $6.73 to $7.33. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]Stock options are fully vested and exercisable.